Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up
Clinical and Experimental Dermatology2016Vol. 41(8), pp. 852–857
Citations Over TimeTop 10% of 2016 papers
Abstract
Oral clindamycin with oral rifampicin for 12 weeks is an effective and tolerable regimen for HS.
Related Papers
- → Oral ofloxacin and clindamycin as an alternative to the classic rifampicin–clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients(2017)24 cited
- → Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin–rifampicin combination for hidradenitis suppurativa?(2018)18 cited
- → Efficacy of short‐term intravenous clindamycin prior to oral clindamycin–rifampicin treatment in hidradenitis suppurativa: a retrospective case series(2021)10 cited
- → 064 Short-term intravenous clindamycin accelerates the benefit of oral clindamycin-rifampicin treatment in hidradenitis suppurativa (HS)(2021)
- → ESDR064 - Short-term intravenous clindamycin accelerates the benefit of oral clindamycin-rifampicin treatment in hidradenitis suppurativa (HS)(2021)